Comparison of Treatment Outcomes of Selective Laser Trabeculoplasty for Primary Open-Angle Glaucoma and Pseudophakic Primary Angle-Closure Glaucoma Receiving Maximal Medical Therapy

Selective laser trabeculoplasty (SLT) is a useful treatment for intraocular pressure (IOP) control. However, there are only a few reports which compare the outcomes of SLT between primary open-angle glaucoma (POAG) and primary angle-closure glaucoma (PACG). We compared the efficacy of SLT for patients with PACG following phacoemulsification with POAG receiving maximal medical therapy (MMT). Consecutive glaucoma patients followed up for at least 1 year after SLT were retrospectively evaluated and IOP reductions at 6 months and 12 months were analyzed. Seventy-six patients were included in the analyses. The baseline IOPs in the POAG and PACG group were 18.5 ± 3.3 mmHg and 16.9 ± 2.5 mmHg, respectively, with 2.8 ± 0.9 and 2.7 ± 0.8 types of IOP lowering medication. The average IOP at the 6-month and 12-month follow-up after SLT was significantly decreased and comparable in both the POAG and PACG groups. For those with a low baseline IOP, the effect of SLT on IOP reduction at 12 months was significantly better in the PACG than in the POAG group (p = 0.003). IOP reduction at 6 and 12 months after SLT was significantly greater in those with a high baseline IOP than those with a low baseline IOP (p < 0.0065). In summary, the one-year efficacy of SLT was equivalent in POAG and pseudophakic PACG patients receiving MMT; however, SLT was more effective in eyes with PACG than eyes with POAG when focusing on those with a lower baseline IOP.

[1]  N. Kurysheva,et al.  Selective Laser Trabeculoplasty Protects Glaucoma Progression in the Initial Primary Open-Angle Glaucoma and Angle-Closure Glaucoma after Laser Peripheral Iridotomy in the Long Term , 2019, BioMed research international.

[2]  C. Bunce,et al.  Primary Selective Laser Trabeculoplasty for Open-Angle Glaucoma and Ocular Hypertension: Clinical Outcomes, Predictors of Success, and Safety from the Laser in Glaucoma and Ocular Hypertension Trial. , 2019, Ophthalmology.

[3]  C. Bunce,et al.  Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial , 2019, The Lancet.

[4]  S. Senthil,et al.  Comparison of Visual Field Progression Rates Among the High Tension Glaucoma, Primary Angle Closure Glaucoma, and Normal Tension Glaucoma. , 2019, Investigative ophthalmology & visual science.

[5]  N. Kurysheva,et al.  Predictors of Outcome in Selective Laser Trabeculoplasty: A Long-term Observation Study in Primary Angle-closure Glaucoma After Laser Peripheral Iridotomy Compared With Primary Open-angle Glaucoma , 2018, Journal of glaucoma.

[6]  M. De Belder,et al.  Selective laser trabeculoplasty as replacement therapy in medically controlled glaucoma patients , 2018, Acta ophthalmologica.

[7]  P. Ichhpujani,et al.  Efficacy of selective laser trabeculoplasty in primary angle closure disease , 2018, Eye.

[8]  Shan C. Lin,et al.  Trabecular Meshwork Height in Primary Open-Angle Glaucoma Versus Primary Angle-Closure Glaucoma. , 2017, American journal of ophthalmology.

[9]  S. Asrani,et al.  Feasibility of laser trabeculoplasty in angle closure glaucoma: a review of favourable histopathological findings in narrow angles , 2017, Clinical & experimental ophthalmology.

[10]  Dao-Yi Yu,et al.  Primary angle closure glaucoma: What we know and what we don’t know , 2017, Progress in Retinal and Eye Research.

[11]  V. D. Groot,et al.  Selective laser trabeculoplasty in pseudophakic and phakic eyes: a prospective study. , 2017 .

[12]  Flavio S. Lopes,et al.  Selective laser trabeculoplasty for early glaucoma: analysis of success predictors and adjusted laser outcomes based on the untreated fellow eye , 2016, BMC Ophthalmology.

[13]  K. Nishida,et al.  Treatment Outcomes and Prognostic Factors of Selective Laser Trabeculoplasty for Open-angle Glaucoma Receiving Maximal-tolerable Medical Therapy , 2016, Journal of glaucoma.

[14]  Augusto Azuara-Blanco,et al.  Effectiveness of early lens extraction for the treatment of primary angle-closure glaucoma (EAGLE): a randomised controlled trial , 2016, The Lancet.

[15]  D. Edward,et al.  Selective Laser Trabeculoplasty in Primary Angle-closure Glaucoma After Laser Peripheral Iridotomy: A Case-Control Study , 2016, Journal of glaucoma.

[16]  J. Lai,et al.  Optimal Selective Laser Trabeculoplasty Energy for Maximal Intraocular Pressure Reduction in Open-Angle Glaucoma , 2015, Journal of glaucoma.

[17]  T. Aung,et al.  The role of lens extraction in the current management of primary angle-closure glaucoma , 2015, Current opinion in ophthalmology.

[18]  G. Seymenoğlu,et al.  Efficacy of Selective Laser Trabeculoplasty in Phakic and Pseudophakic Eyes , 2015, Journal of glaucoma.

[19]  T. Aung,et al.  Efficacy of Selective Laser Trabeculoplasty in Primary Angle-Closure Glaucoma , 2015 .

[20]  Mandy O M Wong,et al.  Systematic review and meta-analysis on the efficacy of selective laser trabeculoplasty in open-angle glaucoma. , 2015, Survey of ophthalmology.

[21]  Shriji N. Patel,et al.  Selective Laser Trabeculoplasty in the Treatment of Glaucoma in Phakic Versus Pseudophakic Patients , 2013 .

[22]  Dennis S C Lam,et al.  Phacoemulsification versus trabeculectomy in medically uncontrolled chronic angle-closure glaucoma without cataract. , 2013, Ophthalmology.

[23]  Shan C. Lin,et al.  Long-term outcomes of laser iridotomy in Vietnamese patients with primary angle closure , 2010, British Journal of Ophthalmology.

[24]  C. Tham,et al.  Phacoemulsification versus combined phacotrabeculectomy in medically controlled chronic angle closure glaucoma with cataract. , 2008, Ophthalmology.

[25]  C. Tham,et al.  The Clinical Outcomes of Cataract Extraction by Phacoemulsification in Eyes With Primary Angle-Closure Glaucoma (PACG) and Co-Existing Cataract: A Prospective Case Series , 2006, Journal of glaucoma.